v3.26.1
STATEMENT OF CASH FLOWS - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2025
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:                
Net loss $ (590)   $ (10,000)          
Changes in operating assets and liabilities:                
Accrued Expenses 590              
Payment of expenses through related party     10,000          
Net cash used in operating activities            
Cash flows from investing activities:                
Net cash (used in) provided by investing activities            
Cash flows from financing activities:                
Net cash provided by (used in) financing activities            
Net change in cash and cash equivalents            
Cash and cash equivalents at the beginning of the period            
Cash and cash equivalents at the end of period        
Supplemental schedule of non-cash financing activities:                
Common stock issued to initial shareholder for subscription fee 100              
D. Boral ARC Acquisition I Corp [Member]                
Cash flows from operating activities:                
Net loss   $ 5,420 2,011,318   4,455,970      
Changes in operating assets and liabilities:                
Accrued Expenses   308,102   37,611      
Investment income in trust account   (2,543,059)   (4,776,628)      
Payment of expenses through promissory note – related party   5,420   41,420      
Prepaid expenses   46,875   (203,134)      
Net cash used in operating activities   (176,764)   (444,761)      
Cash flows from investing activities:                
Investment of cash in Trust Account     (280,000,000)      
Net cash (used in) provided by investing activities         (280,000,000)      
Cash flows from financing activities:                
Proceeds from issuance of Class B ordinary shares to Sponsor     25,000      
Proceeds from sale of Units, net of underwriting discount paid     280,000,000      
Proceeds from sale of private placement units     2,000,000      
Repayment of promissory note     (225,461)      
Payment of offering costs     (934,438)      
Net cash provided by (used in) financing activities     280,865,101      
Net change in cash and cash equivalents   (176,764)   420,340      
Cash and cash equivalents at the beginning of the period   420,340        
Cash and cash equivalents at the end of period $ 420,340 243,576 243,576 420,340    
Supplemental schedule of non-cash financing activities:                
Forfeiture of founder shares         32      
Re-measurement of ordinary shares subject to redemption         $ 4,776,628      
Issuance of representative shares         2,419,400      
Deferred offering costs included in promissory note   48,420          
Accretion of carrying value of redeemable shares to redemption value   2,543,059          
Exascale Labs Inc. [Member]                
Cash flows from operating activities:                
Net loss     (2,632,431) (7,916,977)   (6,178,537) $ (7,659,667) $ (4,956,347)
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation of equipment     1,565 5,194   4,633 6,234 4,110
Share-based compensation         153,266 153,266 21,104
Change in fair value of simple agreements for future equity       5,098,320   3,716,052 4,614,821 3,110,518
Other operating activities settled in digital assets and U.S. Dollar Coin       (1,681,167)      
Changes in operating assets and liabilities:                
Accounts receivable       (1,677,569)   (10,483) (29,204) (123,332)
Advance to suppliers       923,960   (278,612) (750,264) (280,497)
Prepaid research and development expenses       (625,000)      
Refundable deposits receivable       171,125   (150,000) (571,125) (100,000)
Other receivables       1,707,626   1,835,770 1,709,568 1,515,306
Accounts payable       653,727   (104,717) (38,025) 128,040
Contract liabilities       (323,103)   144,082 337,434 95,326
Refundable deposits payable       (270,878)   224,279 1,222,375 223,205
Other current liabilities       176,131   (113,693) (6,212) (198,342)
Net cash used in operating activities       (3,758,611)   (757,960) (1,010,799) (560,909)
Cash flows from investing activities:                
Disposal of digital assets and U.S. Dollar Coin       606,752      
Purchase of equipment         (2,138) (2,138) (27,806)
Net cash (used in) provided by investing activities       606,752   (2,138) (2,138) (27,806)
Cash flows from financing activities:                
Payment for deferred offering costs       (95,000)      
Proceeds from Simple agreements for future equity         4,275,000 4,275,000 1,285,000
Net cash provided by (used in) financing activities       (95,000)   4,275,000 4,275,000 1,285,000
Net change in cash and cash equivalents       (3,246,859)   3,514,902 3,262,063 696,285
Cash and cash equivalents at the beginning of the period       4,231,689   969,626 969,626 273,341
Cash and cash equivalents at the end of period   $ 4,484,528 $ 984,830 984,830   4,484,528 4,231,689 969,626
Supplemental schedule of non-cash financing activities:                
Investment proceeds received by an employee on behalf of the Company from SAFEs investors       500,000   32,500 4,400,000
Supplementary Information:                
Income tax paid        
Interest expense paid        
Investment proceeds received through USDC from SAFEs investors       $ 3,000,000